TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Octapharma Nordic AB
Closing information (x1000 NOK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover |
30,024,840
|
25,090,674
|
25,158,213 |
Financial expenses |
35,380
|
212,062
|
10,617 |
Earnings before taxes |
5,385,096
|
4,719,233
|
4,135,663 |
EBITDA |
6,854,481
|
6,336,517
|
5,469,713 |
Total assets |
44,560,567
|
38,725,095
|
35,880,157 |
Current assets |
31,870,450
|
27,137,720
|
25,285,512 |
Current liabilities |
4,199,969
|
3,907,272
|
3,252,849 |
Equity capital |
38,096,082
|
32,903,498
|
30,607,733 |
- share capital |
1,263
|
1,200
|
1,051 |
Employees (average) |
9,734
|
8,336
|
8,141 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency |
85.5%
|
85.0%
|
85.3% |
Turnover per employee |
3,085
|
3,010
|
3,090 |
Profit as a percentage of turnover |
17.9%
|
18.8%
|
16.4% |
Return on assets (ROA) |
12.2%
|
12.7%
|
11.6% |
Current ratio |
758.8%
|
694.5%
|
777.3% |
Return on equity (ROE) |
14.1%
|
14.3%
|
13.5% |
Change turnover |
5,688,247
|
1,670,654
|
927,028 |
Change turnover % |
23%
|
7%
|
4% |
Chg. No. of employees |
1,398
|
195
|
233 |
Chg. No. of employees % |
17%
|
2%
|
3% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.